Form 4: Vistra CEO Exercises Options, Sells Shares Under 10b5-1 Plan
Insider Transaction Report
Vistra Corp.'s President and CEO, James A. Burke, exercised stock options and subsequently sold a portion of the acquired common stock under a pre-arranged 10b5-1 trading plan.
Summary
- James A. Burke, President and CEO of Vistra Corp. (VST), engaged in transactions involving the company's common stock on September 22 and 23, 2025.
- On September 22, 2025, Burke exercised 2016 employee stock options to acquire 19,200 shares at $14.03 and 2018 employee stock options to acquire 4,800 shares at $19.68.
- On the same day, Burke sold 21,362 shares of common stock at a weighted-average price of $210.83, which included 1,732 shares for cashless exercise and 8,766 shares to cover tax obligations.
- On September 23, 2025, Burke again exercised 2016 employee stock options to acquire 19,200 shares at $14.03 and 2018 employee stock options to acquire 4,800 shares at $19.68.
- Also on September 23, 2025, Burke sold 2,160 shares at a weighted-average price of $212.11 (including 446 for cashless exercise and 1,714 for taxes) and an additional 19,200 shares at $210 (including 1,289 for cashless exercise and 7,051 for taxes).
- All reported transactions were executed pursuant to a Rule 10b5-1 trading plan adopted by Burke on June 12, 2025.
- Following these transactions, Burke directly owns 238,520 shares of common stock.
- Indirect beneficial ownership includes 701,514 shares through JAMEB, LP, 34,000 shares through the James A. Burke 2012 Irrevocable Trust, and 259 shares through the Marti E. Burke 2012 Irrevocable Trust.
Sentiment
Score: 7
Explanation: The transactions represent a routine exercise of stock options and subsequent sale of shares under a pre-arranged 10b5-1 trading plan. The sales were executed at significantly higher prices than the option exercise prices, indicating a profitable and planned liquidity event for the executive, rather than a reaction to negative company performance or outlook.
Positives
- The exercise of stock options and subsequent sale of shares were executed under a pre-arranged Rule 10b5-1 trading plan, indicating a planned and routine transaction rather than a reaction to new, adverse information.
- The sale prices of the common stock (ranging from $210.458 to $212.35) are significantly higher than the exercise prices of the options ($14.03 and $19.68), indicating a substantial profit for the reporting person.
Negatives
- The disposition of a significant number of shares by a high-ranking insider (President and CEO) could be perceived negatively by some investors, even if pre-planned.
Future Outlook
N/A
Industry Context
N/A
Related Party Transactions
- Indirect beneficial ownership of 701,514 shares through JAMEB, LP, a limited partnership jointly owned by the reporting person and his spouse.
- Indirect beneficial ownership of 34,000 shares through the James A. Burke 2012 Irrevocable Trust.
- Indirect beneficial ownership of 259 shares through the Marti E. Burke 2012 Irrevocable Trust.
Stakeholder Impact
- Shareholders: The sale of shares by a key executive, even if pre-planned, could be interpreted by some as a lack of confidence, though the 10b5-1 plan mitigates this. The transactions are a routine part of executive compensation and liquidity management.
Key Dates
| Date | Description |
|---|---|
| 10/03/2017 | Start of vesting for 2016 Employee Stock Options. |
| 06/12/2025 | Rule 10b5-1 trading plan adopted by the reporting person. |
| 09/22/2025 | Transaction date for option exercises and share sales. |
| 09/23/2025 | Transaction date for option exercises and share sales. |
| 09/24/2025 | Filing date of the Form 4. |
| 10/11/2026 | Expiration date for 2016 Employee Stock Options. |
| 04/09/2027 | Expiration date for 2018 Employee Stock Options. |
Recommendation
holdThe Form 4 filing details routine insider transactions involving the exercise of stock options and subsequent sale of shares under a pre-established 10b5-1 trading plan. These transactions are a common part of executive compensation and personal financial planning and do not typically signal a change in the company's fundamental outlook or performance. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as there is no new information to warrant a change in investment thesis.
Keywords
Vistra Corp., VST, insider trading, Form 4, stock options, CEO, share sale, 10b5-1 plan, beneficial ownership, executive compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.